Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

It doesn’t explain why, but some investors are speculating ... the three that has a product on the market. Along with partner Vertex Pharmaceuticals, it has won regulatory approval for Casgevy ...

A majority of 29 out of 55 Copenhagen City Council members voted to name a location "Palestine Square", it was announced on Thursday. The new name is set to take effect on April 1. The discussion ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

(AP Photo/Frank Franklin II, File) NEW YORK (AP) — Big boxing in New York for long meant Madison Square Garden, in recent years Barclays Center as well. Fight night in Times Square promises to be a ...

A tariff is a tax imposed on imported goods and services that can be used to protect domestic industries, raise revenues, and serve to punish foreign countries for unfair trade practices. They are ...

Theoretical physicists have proposed a potential solution to one of the most puzzling problems in modern physics: the black hole singularity paradox. By modifying Einstein's theory of general ...

In the latest quarter, 8 analysts provided ratings for Vertex VERX, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...

Vertex's total revenues for Q4 2024 were $178.5 million, marking a 15.2% increase year-over-year. How much did Vertex invest in research and development for 2025? Vertex plans to invest ...

Exploring a mapping among n-state spin and vertex models on the square lattice, we argue that a given integrable spin model with edge weights satisfying the rapidity difference property can be ...